Paper35531007
Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model.
Li Y and 5 others. RSC Adv, 2019. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model. Papers, record 35531007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35531007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29204251 | Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/29204251 | PubMed |
| 2 | 26481049 | Hederagenin, a major component of Clematis mandshurica Ruprecht root, attenuates inflammatory responses in RAW 264.7 cells and in mice. | Int Immunopharmacol | 2015 | https://conductscience.org/library/papers/26481049 | PubMed |
| 3 | 28934669 | Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy. | Diabetes Res Clin Pract | 2017 | https://conductscience.org/library/papers/28934669 | PubMed |
| 4 | 21617109 | Globalization of diabetes: the role of diet, lifestyle, and genes. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21617109 | PubMed |
| 5 | 28067819 | Hederagenin Supplementation Alleviates the Pro-Inflammatory and Apoptotic Response to Alcohol in Rats. | Nutrients | 2017 | https://conductscience.org/library/papers/28067819 | PubMed |
| 6 | 29669543 | Diabetes, cardiovascular disease and the microcirculation. | Cardiovasc Diabetol | 2018 | https://conductscience.org/library/papers/29669543 | PubMed |
| 7 | 26705059 | Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. | J Mol Cell Cardiol | 2016 | https://conductscience.org/library/papers/26705059 | PubMed |
| 8 | 23932046 | An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. | Int J Cardiol | 2013 | https://conductscience.org/library/papers/23932046 | PubMed |
| 9 | 26557859 | Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats. | Evid Based Complement Alternat Med | 2015 | https://conductscience.org/library/papers/26557859 | PubMed |
| 10 | 27017553 | Novel hederagenin-triazolyl derivatives as potential anti-cancer agents. | Eur J Med Chem | 2016 | https://conductscience.org/library/papers/27017553 | PubMed |
| 11 | 27941647 | The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27941647 | PubMed |
| 12 | 29449364 | Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. | Circ Res | 2018 | https://conductscience.org/library/papers/29449364 | PubMed |
| 13 | 28776083 | Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. | Diabetologia | 2018 | https://conductscience.org/library/papers/28776083 | PubMed |
| 14 | 27339889 | Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. | Nat Rev Endocrinol | 2016 | https://conductscience.org/library/papers/27339889 | PubMed |
| 15 | 21328257 | Herbal therapy for treating rheumatoid arthritis. | Cochrane Database Syst Rev | 2011 | https://conductscience.org/library/papers/21328257 | PubMed |
| 16 | 28395009 | An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. | Cardiovasc Res | 2017 | https://conductscience.org/library/papers/28395009 | PubMed |
| 17 | 21772278 | Crosstalk in NF-κB signaling pathways. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21772278 | PubMed |
| 18 | 26477373 | Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice. | J Ethnopharmacol | 2015 | https://conductscience.org/library/papers/26477373 | PubMed |
| 19 | 20586941 | Herbal medicines and chronic kidney disease. | Nephrology (Carlton) | 2010 | https://conductscience.org/library/papers/20586941 | PubMed |
| 20 | 30017632 | New insights into TGF-β/Smad signaling in tissue fibrosis. | Chem Biol Interact | 2018 | https://conductscience.org/library/papers/30017632 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41749398 | Hederagenin Attenuates Cardiac Remodeling by Targeting Phosphodiesterase 9A. | Phytother Res | 2026 | https://conductscience.org/library/papers/41749398 | PubMed |
| 41743998 | Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms. | J Nutr Metab | 2026 | https://conductscience.org/library/papers/41743998 | PubMed |
| 41341866 | Biomimetic Nanoplatform Based on the Neutrophil Membrane for Targeted Therapy of Spinal Cord Injury. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41341866 | PubMed |
| 41140079 | Recent Advancements in Pentacyclic and Other Terpenoid Derivatives as Anti-inflammatory Agents. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41140079 | PubMed |
| 40771280 | Therapeutic potential of traditional Chinese medicine in diabetic cardiomyopathy: a review. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40771280 | PubMed |
| 40511498 | Hederagenin promotes SIRT6 to attenuate epidural scar formation by aggravating PRMT1 deacetylation. | Bone Joint Res | 2025 | https://conductscience.org/library/papers/40511498 | PubMed |
| 40142049 | Current Progress of Hederagenin and Its Derivatives for Disease Therapy (2017-Present). | Molecules | 2025 | https://conductscience.org/library/papers/40142049 | PubMed |
| 39383136 | Hederagenin regulates the migration and invasion of hepatocellular carcinoma cells through FOXO signaling pathway. | PLoS One | 2024 | https://conductscience.org/library/papers/39383136 | PubMed |
| 39082169 | Efficacy and Mechanism of Core Traditional Chinese Medicines for Treating Malignant Lymphoma based on Efficacy Studies: A Study Supported by Network Pharmacology and Molecular Docking. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/39082169 | PubMed |
| 39021834 | The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39021834 | PubMed |
| 38962311 | An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38962311 | PubMed |
| 38927307 | A Traditional Chinese Medicine, Zhenqi Granule, Potentially Alleviates Dextran Sulfate Sodium-Induced Mouse Colitis Symptoms. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/38927307 | PubMed |
| 38707342 | NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies. | Heliyon | 2024 | https://conductscience.org/library/papers/38707342 | PubMed |
| 38476892 | Biochanin A inhibits endothelial dysfunction induced by IL‑6‑stimulated endothelial microparticles in Perthes disease via the NFκB pathway. | Exp Ther Med | 2024 | https://conductscience.org/library/papers/38476892 | PubMed |
| 37955689 | Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37955689 | PubMed |
| 37859723 | Pharmacological overview of hederagenin and its derivatives. | RSC Med Chem | 2023 | https://conductscience.org/library/papers/37859723 | PubMed |
| 34234695 | Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response. | Front Physiol | 2021 | https://conductscience.org/library/papers/34234695 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35531007
GET https://conductscience.org/api/papers/v1/35531007/references?page=2